CHICAGO EQUITY PARTNERS LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$1,509,000
-31.3%
15,145
-20.8%
0.15%
+20.6%
Q4 2019$2,196,000
-28.1%
19,115
-21.0%
0.13%
-13.1%
Q3 2019$3,053,000
+49.6%
24,205
+42.7%
0.14%
+59.3%
Q2 2019$2,041,000
+36.5%
16,960
-0.7%
0.09%
+56.9%
Q1 2019$1,495,000
-57.6%
17,085
-51.6%
0.06%
-59.2%
Q4 2018$3,530,000
-34.5%
35,285
-24.9%
0.14%
-10.1%
Q3 2018$5,386,000
-30.7%
47,005
-45.8%
0.16%
-33.6%
Q2 2018$7,772,000
+64.3%
86,665
+34.0%
0.24%
+57.6%
Q1 2018$4,731,000
+297.2%
64,665
+215.3%
0.15%
+319.4%
Q4 2017$1,191,00020,5100.04%
Other shareholders
HAEMONETICS CORP shareholders Q4 2017
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders